Add to Calendar2019-09-20 08:00:002019-09-21 11:15:00Emerging Topic Conference: The Genomics Revolution
The conference will focus on genomics and the changing approach to diagnostics, management and research in adult and pediatric liver diseases.
Arlington, VA 22202
Add to Calendar2019-10-04 08:00:002019-10-05 14:00:00AASLD / EASL ALD Conference
This meeting will bridge critical gaps in ALD diagnosis, management and clinical trial design.
1 W. Wacker Drive
Chicago, IL 60601
Add to Calendar2019-11-08 09:00:002019-11-12 14:00:00The Liver Meeting
The Liver MeetingÂ® is the annual must-attend event bringing together 9,500 attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field.
Add to Calendar2019-12-14 08:00:002019-12-15 17:00:00TASL-AASLD Joint Symposium: HBV Elimination
Doctors Anna S. Lok and K. Rajender Reddy will join Dr. Jia-Horng Kao and other faculty from Taiwan to host the first TASL-AASLD Joint Symposium as part of the TASL (Taiwan Association for the Study of the Liver) Annual Meeting, December 14-15, 2019 in Taipei.
Beitou District, Taipei City
Add to Calendar2020-03-20 08:00:002020-03-21 15:00:00Emerging Topic Conference: Nuclear Receptors as Common Clinical Targets for the Treatment of Cholestatic and Nonalcoholic Fatty Liver Diseases
More information is coming soon.
LiverLearningÂ® is the official eLearning portal of AASLD. Users can access educational resources by topic, speaker, event, and content type â€” including video, audio, and slide decks. Continuing education (CME/CE credits and MOC points) is available for a variety of enduring materials on the portal. All current AASLD members automatically receive complete access to LiverLearningÂ®, and non-members can purchase access for one year with a subscription.
The Medical Director, Hepatobiliary Cancers (HB) will work closely with the Screening Business Unit leadership team, and be responsible for development and execution of the company’s hepatocellular carcinoma (HCC) surveillance and other related pipeline strategies; including, but not limited to, the design and implementation of hepatobiliary cancer early detection test development, validation, regulatory approval, evidence generation, guideline inclusion and contracting/reimbursement pathways. In partnership with the R&D and pipeline teams, this role will provide key medical
This job listing is no longer active.
Check the left side of the screen for similar opportunities.